Compound information
- Natural Products
- ZC2211043
- Molecular Formula
- C19H22ClN3O2
- Molecular Weight
- 359.140054624 g/mol
- Structure
-
- IUPAC Name
- 4-[(3-chlorophenyl)methyl]-N-(3-methoxyphenyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C19H22ClN3O2/c1-25-18-7-3-6-17(13-18)21-19(24)23-10-8-22(9-11-23)14-15-4-2-5-16(20)12-15/h2-7,12-13H,8-11,14H2,1H3,(H,21,24)
- InChI Key
- GYRHUWIFZZAYNE-UHFFFAOYSA-N
- SMILES
- COc1cccc(NC(=O)N2CCN(Cc3cccc(Cl)c3)CC2)c1
- Source
- ZINC000020274445
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 44.81 Å2 | LogP | 3.657 |
LogS | -3.895 | LogD | 4.006 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.963 | Pgp substrate | 0.501 |
HIA | 0.968 | F20 % | 0.993 |
F30 % | 0.955 | Caco-2 | -4.768 |
MDCK | -4.74 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.758 | PPB | 96.949 |
VD | 1.258 | Fu | 1.351 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.021 | CYP1A2 substrate | 0.747 |
CYP2A6 substrate | 0.693 | CYP2B6 substrate | 0.553 |
CYP2C19 inhibitor | 0.987 | CYP2C19 substrate | 0.963 |
CYP2C8 substrate | 0.88 | CYP2C9 inhibitor | 0.512 |
CYP2C9 substrate | 0.023 | CYP2D6 inhibitor | 0.977 |
CYP2D6 substrate | 0.982 | CYP2E1 substrate | 0.602 |
CYP3A4 inhibitor | 0.83 | CYP3A4 substrate | 0.948 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.514 | CL | 10.364 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.994 | Hepatotoxicity | 0.877 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.679 |
FDAMDD | 0.501 | Skin Sensitization | 0.969 |
Carcinogenicity | 0.024 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.974 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.6 | IGC50 | 3.745 |
LC50FM | 3.618 | LC50DM | -0.832 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.343 | NR-AR-LBD | 0.179 |
NR-AhR | 0.649 | NR-Aromatase | 0.027 |
NR-ER | 0.358 | NR-ER-LBD | 0.304 |
NR-PPAR-gamma | 0.155 | SR-ARE | 0.875 |
SR-ATAD5 | 0.391 | SR-HSE | 0.098 |
SR-MMP | 0.027 | SR-p53 | 0.076 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.